Richard K. Bogan

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy. CNS Drugs. 2023 Mar 22. PMID: 36947322.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Mignot E, Bogan RK, Emsellem H, Foldvary-Schaefer N, Naylor M, Neuwirth R, Faessel H, Swick T, Olsson T. Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia. Sleep. 2023 Mar 08. PMID: 36883238.
      Citations:    Fields:    
    3. Dauvilliers Y, Bogan RK, Arnulf I, Scammell TE, St Louis EK, Thorpy MJ. Clinical considerations for the diagnosis of idiopathic hypersomnia. Sleep Med Rev. 2022 Dec; 66:101709. PMID: 36401976.
      Citations: 1     Fields:    
    4. Thorpy MJ, Arnulf I, Foldvary-Schaefer N, Morse AM, ?onka K, Chandler P, Hickey L, Chen A, Black J, Sterkel A, Chen D, Bogan RK, Dauvilliers Y. Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia. Nat Sci Sleep. 2022; 14:1901-1917. PMID: 36320423; PMCID: PMC9618250.
      Citations:    
    5. Bogan R, Thorpy MJ, Winkelman JW, Dubow J, Gudeman J, Seiden D. Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers. Sleep Med. 2022 Dec; 100:442-447. PMID: 36252412.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    6. Cederberg KLJ, Hanif U, Peris Sempere V, Hédou J, Leary EB, Schneider LD, Lin L, Zhang J, Morse AM, Blackman A, Schweitzer PK, Kotagal S, Bogan R, Kushida CA, Ju YS, Petousi N, Turnbull CD, Mignot E, Cederberg KLJ, Hanif U, Peris Sempere V, H?dou J, Leary EB, Schneider LD, Lin L, Zhang J, Morse AM, Blackman A, Schweitzer PK, Kotagal S, Bogan R, Kushida CA, Ju YS, Petousi N, Turnbull CD, Mignot E. Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response. Int J Mol Sci. 2022 Jul 20; 23(14). PMID: 35887329; PMCID: PMC9317550.
      Citations: 2     Fields:    Translation:Humans
    7. Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ, Dauvilliers Y, ?onka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ. Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications. CNS Drugs. 2022 Jul; 36(7):785-786. PMID: 35764867; PMCID: PMC9259537.
      Citations:    Fields:    
    8. Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ, Dauvilliers Y, ?onka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications. CNS Drugs. 2022 06; 36(6):633-647. PMID: 35635687; PMCID: PMC9213292.
      Citations:    Fields:    Translation:Humans
    9. Roth T, Dauvilliers Y, Thorpy MJ, Kushida C, Corser BC, Bogan R, Rosenberg R, Dubow J, Seiden D, Roth T, Dauvilliers Y, Thorpy MJ, Kushida C, Corser BC, Bogan R, Rosenberg R, Dubow J, Seiden D. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial. CNS Drugs. 2022 04; 36(4):377-387. PMID: 35380374; PMCID: PMC8994715.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    10. Dauvilliers Y, Bogan RK, Šonka K, Partinen M, Foldvary-Schaefer N, Thorpy MJ, Dauvilliers Y, Bogan RK, ?onka K, Partinen M, Foldvary-Schaefer N, Thorpy MJ. Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. Nat Sci Sleep. 2022; 14:531-546. PMID: 35378745; PMCID: PMC8976528.
      Citations:    
    11. Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, Šonka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK, Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, Morse AM, ?onka K, Thorpy MJ, Mignot E, Chandler P, Parvataneni R, Black J, Sterkel A, Chen D, Skobieranda F, Bogan RK. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study. Lancet Neurol. 2022 01; 21(1):53-65. PMID: 34942138.
      Citations:    
    12. Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, Šonka K, Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, ?onka K. Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep. 2021 Nov 12; 44(11). PMID: 34387692; PMCID: PMC8598178.
      Citations:    
    13. Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, Šonka K, Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, ?onka K. Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adults With Narcolepsy With Cataplexy. Sleep. 2021 Jul 09; 44(7). PMID: 34223903; PMCID: PMC8271133.
      Citations:    
    14. Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, Šonka K, Bogan RK, Thorpy MJ, Dauvilliers Y, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Tang L, Skobieranda F, ?onka K. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy. Sleep. 2021 03 12; 44(3). PMID: 33184650; PMCID: PMC7953213.
      Citations:    
    15. Weaver TE, Drake CL, Benes H, Stern T, Maynard J, Thein SG, Andry JM, Hudson JD, Chen D, Carter LP, Bron M, Lee L, Black J, Bogan RK, Weaver TE, Drake CL, Benes H, Stern T, Maynard J, Thein SG, Andry JM, Hudson JD, Chen D, Carter LP, Bron M, Lee L, Black J, Bogan RK. Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial. Ann Am Thorac Soc. 2020 08; 17(8):998-1007. PMID: 32353246; PMCID: PMC7393785.
      Citations:    
    16. Thorpy MJ, Bogan RK, Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med. 2020 04; 68:97-109. PMID: 32032921.
      Citations:    
    17. Cairns A, Bogan R, Cairns A, Bogan R. The SinuSonic: reducing nasal congestion with acoustic vibration and oscillating expiratory pressure. Med Devices (Auckl). 2019; 12:305-310. PMID: 31695522; PMCID: PMC6718060.
      Citations:    
    18. Bogan RK, Bogan RK. Getting Serious about Excessive Sleepiness. Sleep Health. 2019 08; 5(4):319. PMID: 31400881.
      Citations:    
    19. Cairns A, Bogan R, Cairns A, Bogan R. Comparison of the macro and microstructure of sleep in a sample of sleep clinic hypersomnia cases. Neurobiol Sleep Circadian Rhythms. 2019 Jan; 6:62-69. PMID: 31236521; PMCID: PMC6586604.
      Citations:    
    20. Cairns A, Trotti LM, Bogan R, Cairns A, Trotti LM, Bogan R. Demographic and nap-related variance of the MSLT: results from 2,498 suspected hypersomnia patients: Clinical MSLT variance. Sleep Med. 2019 03; 55:115-123. PMID: 30785052; PMCID: PMC6411434.
      Citations:    
    21. Sharon D, Allen RP, Martinez-Martin P, Walters AS, Ferini Strambi L, Högl B, Trotti LM, Buchfuhrer M, Swieca J, Bogan RK, Zak R, Hensley JG, Schaefer LA, Marelli S, Zucconi M, Stefani A, Holzknecht E, Olvera V, Meaklim H, Laska I, Becker PM, Sharon D, Allen RP, Martinez-Martin P, Walters AS, Ferini Strambi L, H?gl B, Trotti LM, Buchfuhrer M, Swieca J, Bogan RK, Zak R, Hensley JG, Schaefer LA, Marelli S, Zucconi M, Stefani A, Holzknecht E, Olvera V, Meaklim H, Laska I, Becker PM, International RLS Study Group. Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS. Sleep Med. 2019 02; 54:94-100. PMID: 30529783.
      Citations:    
    22. Ohayon MM, Black J, Krystal AD, Shapiro CM, Swick TJ, Bogan R, Wells CC, Ohayon MM, Black J, Krystal AD, Shapiro CM, Swick TJ, Bogan R, Wells CC. Longitudinal study of narcolepsy symptoms in first, second, and third-degree relatives of simplex and multiplex narcolepsy families. Sleep Med. 2019 01; 53:88-93. PMID: 30496948.
      Citations:    
    23. Fleming WE, Holty JC, Bogan RK, Hwang D, Ferouz-Colborn AS, Budhiraja R, Redline S, Mensah-Osman E, Osman NI, Li Q, Azad A, Podolak S, Samoszuk MK, Cruz AB, Bai Y, Lu J, Riley JS, Southwick PC, Fleming WE, Holty JC, Bogan RK, Hwang D, Ferouz-Colborn AS, Budhiraja R, Redline S, Mensah-Osman E, Osman NI, Li Q, Azad A, Podolak S, Samoszuk MK, Cruz AB, Bai Y, Lu J, Riley JS, Southwick PC. Use of blood biomarkers to screen for obstructive sleep apnea. Nat Sci Sleep. 2018; 10:159-167. PMID: 29942168; PMCID: PMC6005302.
      Citations:    
    24. Bogan RK, Wells C, Bogan RK, Wells C. A Randomized Crossover Trial of a Pressure Relief Technology (SensAwake?) in Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea. Sleep Disord. 2017; 2017:3978073. PMID: 29410921; PMCID: PMC5749294.
      Citations:    
    25. Geyer J, Bogan R, Geyer J, Bogan R. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations. Postgrad Med. 2017 Sep; 129(7):667-675. PMID: 28818004.
      Citations:    
    26. Bogan RK, Black J, Swick T, Mamelak M, Kovacevic-Ristanovic R, Villa KF, Mori F, Montplaisir J, Bogan RK, Black J, Swick T, Mamelak M, Kovacevic-Ristanovic R, Villa KF, Mori F, Montplaisir J. Correlation of Changes in Patient-Reported Quality of Life With Physician-Rated Global Impression of Change in Patients With Narcolepsy Participating in a Clinical Trial of Sodium Oxybate: A Post Hoc Analysis. Neurol Ther. 2017 Dec; 6(2):237-245. PMID: 28707076; PMCID: PMC5700898.
      Citations:    
    27. Ruoff C, Bogan RK, Emsellem H, Feldman N, Lankford A, Bream G, Khayrallah M, Lu Y, Carter LP, Black J, Ruoff C, Bogan RK, Emsellem H, Feldman N, Lankford A, Bream G, Khayrallah M, Lu Y, Carter LP, Black J. Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes. Sleep Med. 2017 Jul; 35:12-16. PMID: 28619176.
      Citations:    
    28. Cairns A, Sarmiento K, Bogan R, Cairns A, Sarmiento K, Bogan R. Utility of home sleep apnea testing in high-risk veterans. Sleep Breath. 2017 Sep; 21(3):647-655. PMID: 28243925.
      Citations:    
    29. Cairns A, Bogan R, Cairns A, Bogan R. Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic. Sleep Med. 2017 Apr; 32:150-156. PMID: 28366327.
      Citations:    
    30. Bogan R, Swick T, Mamelak M, Kovacevic-Ristanovic R, Lai C, Black J, Villa KF, Montplaisir J, Bogan R, Swick T, Mamelak M, Kovacevic-Ristanovic R, Lai C, Black J, Villa KF, Montplaisir J. Evaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial. Neurol Ther. 2016 Dec; 5(2):203-213. PMID: 27778193; PMCID: PMC5130920.
      Citations:    
    31. Black J, Swick T, Bogan R, Lai C, Carter LP, Black J, Swick T, Bogan R, Lai C, Carter LP. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy. Sleep Med. 2016 08; 24:57-62. PMID: 27810187.
      Citations:    
    32. Alexander M, Ray MA, Hébert JR, Youngstedt SD, Zhang H, Steck SE, Bogan RK, Burch JB, Alexander M, Ray MA, H?bert JR, Youngstedt SD, Zhang H, Steck SE, Bogan RK, Burch JB. The National Veteran Sleep Disorder Study: Descriptive Epidemiology and Secular Trends, 2000-2010. Sleep. 2016 Jul 01; 39(7):1399-410. PMID: 27091538; PMCID: PMC4909622.
      Citations:    
    33. Cairns A, Poulos G, Bogan R, Cairns A, Poulos G, Bogan R. Sex differences in sleep apnea predictors and outcomes from home sleep apnea testing. Nat Sci Sleep. 2016; 8:197-205. PMID: 27418861; PMCID: PMC4935031.
      Citations:    
    34. Cairns A, Bogan R, Cairns A, Bogan R. Prevalence and Clinical Correlates of a Short Onset REM Period (SOREMP) during Routine PSG. Sleep. 2015 Oct 01; 38(10):1575-81. PMID: 26039966; PMCID: PMC4576331.
      Citations:    
    35. Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA, Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy. Sleep Med. 2015 Sep; 16(9):1102-8. PMID: 26298786.
      Citations:    
    36. Bogan RK, Roth T, Schwartz J, Miloslavsky M, Bogan RK, Roth T, Schwartz J, Miloslavsky M. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy. J Clin Sleep Med. 2015 Apr 15; 11(4):427-32. PMID: 25580605; PMCID: PMC4365456.
      Citations:    
    37. Bogan RK, Lee DO, Buchfuhrer MJ, Jaros MJ, Kim R, Shang G, Bogan RK, Lee DO, Buchfuhrer MJ, Jaros MJ, Kim R, Shang G. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil. Ann Med. 2015 May; 47(3):269-77. PMID: 25874578.
      Citations:    
    38. Cairns A, Poulos G, Bogan R, Cairns A, Poulos G, Bogan R. Who is getting tested for obstructive sleep apnea using a portable recording system? Test results from 193,221 patients. J Clin Sleep Med. 2014 Nov 15; 10(11):1193-8. PMID: 25325579; PMCID: PMC4224719.
      Citations:    
    39. Ray MA, Youngstedt SD, Zhang H, Robb SW, Harmon BE, Jean-Louis G, Cai B, Hurley TG, Hébert JR, Bogan RK, Burch JB, Ray MA, Youngstedt SD, Zhang H, Robb SW, Harmon BE, Jean-Louis G, Cai B, Hurley TG, H?bert JR, Bogan RK, Burch JB. Examination of wrist and hip actigraphy using a novel sleep estimation procedure ? Sleep Sci. 2014 Jun; 7(2):74-81. PMID: 25580202; PMCID: PMC4286157.
      Citations:    
    40. Bogan RK, Bogan RK. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome. Clin Ther. 2014 Mar 01; 36(3):436-55. PMID: 24636821.
      Citations:    
    41. Colrain IM, Black J, Siegel LC, Bogan RK, Becker PM, Farid-Moayer M, Goldberg R, Lankford DA, Goldberg AN, Malhotra A, Colrain IM, Black J, Siegel LC, Bogan RK, Becker PM, Farid-Moayer M, Goldberg R, Lankford DA, Goldberg AN, Malhotra A. A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea. Sleep Med. 2013 Sep; 14(9):830-7. PMID: 23871259; PMCID: PMC3932027.
      Citations:    
    42. Bogan RK, Cheray JA, Bogan RK, Cheray JA. Restless legs syndrome: a review of diagnosis and management in primary care. Postgrad Med. 2013 May; 125(3):99-111. PMID: 23748511.
      Citations:    
    43. Barak-Shinar D, Amos Y, Bogan RK, Barak-Shinar D, Amos Y, Bogan RK. Sleep disordered breathing analysis in a general population using standard pulse oximeter signals. Sleep Breath. 2013 Sep; 17(3):1109-15. PMID: 23386370.
      Citations:    
    44. Wright KP, Bogan RK, Wyatt JK, Wright KP, Bogan RK, Wyatt JK. Shift work and the assessment and management of shift work disorder (SWD). Sleep Med Rev. 2013 Feb; 17(1):41-54. PMID: 22560640.
      Citations:    
    45. Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE, Winkelman JW, Bogan RK, Schmidt MH, Hudson JD, DeRossett SE, Hill-Zabala CE. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome. Mov Disord. 2011 Sep; 26(11):2065-72. PMID: 21611981.
      Citations:    
    46. Hening WA, Allen RP, Ondo WG, Walters AS, Winkelman JW, Becker P, Bogan R, Fry JM, Kudrow DB, Lesh KW, Fichtner A, Schollmayer E, Hening WA, Allen RP, Ondo WG, Walters AS, Winkelman JW, Becker P, Bogan R, Fry JM, Kudrow DB, Lesh KW, Fichtner A, Schollmayer E, SP792 Study Group. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord. 2010 Aug 15; 25(11):1675-83. PMID: 20629075.
      Citations:    
    47. Rosenberg R, Bogan R, Rosenberg R, Bogan R. Armodafinil in the treatment of excessive sleepiness. Nat Sci Sleep. 2010; 2:95-105. PMID: 23616702; PMCID: PMC3630938.
      Citations:    
    48. Orr RK, Hoehn JL, Col NF, Rosenberg RP, Bogan RK, Tiller JM, Yang R, Youakim JM, Earl CQ, Roth T. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc. 2010 Jul; 85(7):630-8. PMID: 20530317; PMCID: PMC2894718.
      Citations:    
    49. Bogan RK, Bornemann MA, Kushida CA, Trân PV, Barrett RW, Bogan RK, Bornemann MA, Kushida CA, Tr?n PV, Barrett RW, XP060 Study Group. Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study. Mayo Clin Proc. 2010 Jun; 85(6):512-21. PMID: 20511481; PMCID: PMC2878254.
      Citations:    
    50. Bogan RK, Bogan RK. Armodafinil in the treatment of excessive sleepiness. Expert Opin Pharmacother. 2010 Apr; 11(6):993-1002. PMID: 20307223.
      Citations:    
    51. Youngstedt SD, Kripke DF, Kline CE, Zielinski MR, Bogan RK, Youngstedt SD, Kripke DF, Kline CE, Zielinski MR, Bogan RK. Lack of impairment in glucose tolerance: support for further investigation of sleep restriction in older long sleepers. J Sleep Res. 2010 Mar; 19(1 Pt 1):116-7. PMID: 20470263.
      Citations:    
    52. Kline CE, Zielinski MR, Devlin TM, Kripke DF, Bogan RK, Youngstedt SD, Kline CE, Zielinski MR, Devlin TM, Kripke DF, Bogan RK, Youngstedt SD. Self-reported long sleep in older adults is closely related to objective time in bed. Sleep Biol Rhythms. 2010 Jan; 8(1):42-51. PMID: 25210491; PMCID: PMC4157821.
      Citations:    
    53. Youngstedt SD, Kline CE, Zielinski MR, Kripke DF, Devlin TM, Bogan RK, Wilcox S, Hardin JW, Youngstedt SD, Kline CE, Zielinski MR, Kripke DF, Devlin TM, Bogan RK, Wilcox S, Hardin JW. Tolerance of chronic 90-minute time-in-bed restriction in older long sleepers. Sleep. 2009 Nov; 32(11):1467-79. PMID: 19928386; PMCID: PMC2768953.
      Citations:    
    54. Husain AM, Ristanovic RK, Bogan RK, Husain AM, Ristanovic RK, Bogan RK. Weight loss in narcolepsy patients treated with sodium oxybate. Sleep Med. 2009 Jun; 10(6):661-3. PMID: 19014899.
      Citations:    
    55. Bogan RK, Bogan RK. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance. Postgrad Med. 2008 Sep; 120(3):161-71. PMID: 18824834.
      Citations:    
    56. Zielinski MR, Kline CE, Kripke DF, Bogan RK, Youngstedt SD, Zielinski MR, Kline CE, Kripke DF, Bogan RK, Youngstedt SD. No effect of 8-week time in bed restriction on glucose tolerance in older long sleepers. J Sleep Res. 2008 Dec; 17(4):412-9. PMID: 18691360; PMCID: PMC3244074.
      Citations:    
    57. Bogan RK, Bogan RK. Ropinirole treatment for restless legs syndrome. Expert Opin Pharmacother. 2008 Mar; 9(4):611-23. PMID: 18312162.
      Citations:    
    58. Bogan RK, Turner JA, Bogan RK, Turner JA. New assessment tools that measure sleep vital signs: the SleepMed Insomnia Index and the Sleep Matrix. Neuropsychiatr Dis Treat. 2007 Aug; 3(4):501-10. PMID: 19300579; PMCID: PMC2655088.
      Citations:    
    59. Black J, Duntley SP, Bogan RK, O'Malley MB, Black J, Duntley SP, Bogan RK, O'Malley MB. Recent advances in the treatment and management of excessive daytime sleepiness. CNS Spectr. 2007 Feb; 12(2 Suppl 2):1-14; quiz 15. PMID: 17277717.
      Citations:    
    60. Bogan RK, Bogan RK. Effects of restless legs syndrome (RLS) on sleep. Neuropsychiatr Dis Treat. 2006 Dec; 2(4):513-9. PMID: 19412499; PMCID: PMC2671944.
      Citations:    
    61. Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY, Bogan RK, Fry JM, Schmidt MH, Carson SW, Ritchie SY, TREAT RLS US Study Group. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc. 2006 Jan; 81(1):17-27. PMID: 16438474.
      Citations:    
    62. Schwartz JR, Feldman NT, Bogan RK, Schwartz JR, Feldman NT, Bogan RK. Dose effects of modafinil in sustaining wakefulness in narcolepsy patients with residual evening sleepiness. J Neuropsychiatry Clin Neurosci. 2005; 17(3):405-12. PMID: 16179665.
      Citations:    
    63. Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta JS, Winslow D, Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta JS, Winslow D. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep. 2004 Aug 01; 27(5):907-14. PMID: 15453549.
      Citations:    
    64. Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ, Schwartz JR, Feldman NT, Bogan RK, Nelson MT, Hughes RJ. Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy. Clin Neuropharmacol. 2003 Sep-Oct; 26(5):252-7. PMID: 14520165.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    Bogan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (157)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _